期刊文献+

环氧化酶-2抑制剂联合顺铂治疗肺癌的实验研究 被引量:5

Effect of cyclooxygenase-2 inhibitor, nimesulide, combined with cisplatin on lung cancer
暂未订购
导出
摘要 目的 探讨环氧化酶 2 (COX 2 )抑制剂尼米舒利 (NIM )与化疗药顺铂 (DDP)联合应用治疗肺癌的效应及可能机制。方法 应用MTT试验及流式细胞术分别检测NIM与DDP联用对人肺腺癌A5 49细胞增殖和凋亡的影响 ,裸鼠移植瘤实验检测NIM与DDP联用对A5 49细胞成瘤性的影响。结果 在一定浓度范围内NIM、DDP均可抑制A5 49细胞的生长 ,其抑制作用呈量 效关系。NIM ( 2 5 μmol/L)与DDP合用可增强对A5 49细胞生长的抑制作用 ,DDP浓度≥ 1mg/L时二者有协同或相加作用。NIM及DDP可有效诱导A5 49细胞凋亡 ,联用后凋亡率显著增加。裸鼠移植瘤体内实验显示NIM与DDP均可抑制移植瘤生长 ,联用后抑瘤率显著增高。结论 NIM与DDP联用对A5 49细胞、肺癌移植瘤有显著的协同抗肿瘤效应 ,该作用可能是通过增强对A5 Objective To study the effect and possible mechanism of cyclooxygenase 2 selective inhibitor, nimesulide (NIM), combined with cisplatin (DDP) on human lung cancer. Methods The proliferation and apoptosis of human lung cancer cell line A549 were evaluated by MTT reduction assay and flow cytometry respectively. The inhibitory effects of NIM and DDP to neoplasia were verified on subcutaneous implanted tumor of nude mice. Results Both NIM and DDP could inhibit A549 cell proliferation in a concentration dependent pattern. When NIM (25 μmol/L) and DDP (≥1 mg/L) were combined, the inhibitory effect was enhanced in a synergistic or additive pattern. Both NIM (25 μmol/L) and DDP (3 mg/L) could significantly increase the apoptosis of A549 cells ( P<0.05, P <0.01), and this action was remarkably increased when DDP was combined with NIM ( P<0.01, P <0.01). NIM and DDP could inhibit the growth of subcutaneous implanted tumor on nude mice and the inhibitory rate of NIM combined with DDP was significantly higher than that of NIM or DDP alone ( P<0.01, P <0.01). Conclusion NIM combined with DDP shows significantly synergistic anti tumor effects on lung cancer cell line A549 and subcutaneous implanted tumor on nude mice, which may be achieved by enhancement of growth inhibition and apoptosis induction to tumor cells.
出处 《中国肺癌杂志》 CAS 2004年第3期191-195,共5页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 凋亡 环氧化酶-2 顺铂 Lung neoplasms Apoptosis Cyclooxygenase-2 Cisplatin
  • 相关文献

参考文献1

二级参考文献24

共引文献49

同被引文献68

  • 1Wei Wang~1 Shu-Kui Qin~1 Bao-An Chen~2 Hui-Ying Chen~1 1 Chinese PLA Cancer Center,Chinese PLA 81 Hospital,Nanjing 210002,Jiangshu Province,China2 Affliliated Zhongda Hospital of Southeast University Medical College,Nanjing 210087,Jiangsu Province,China.Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(5):702-705. 被引量:50
  • 2朱红霞,张果,王益华,周翠琦,白瑾峰,徐宁志.非甾类抗炎药通过β-catenin/TCF4-survivin通路诱导结肠癌细胞凋亡[J].癌症,2004,23(7):737-741. 被引量:22
  • 3MacDonald JS, Smalley SIR, Benedetti J, et al. Chemoradiothrea py after surgery compared with surgery alone for adenocarcino ma of the stomach or gastroesophageal junction[J]. N Engl J Med, 2001,345(10) 725 -730.
  • 4Lim DH, Kim DY, Kang MK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and ehemoradiotherapy: a radiation oncologist's view[J]. Brit J of Cancer, 2004, 91 ( 1 ) : 11-17.
  • 5Nasu S, Ang KK, Fan Z, et al. C225 anti-epidermal growth factor receptor antibody enhances tumor radiocurability[J]. Int J Radiat Oncol Biol Phys, 2001,51 (2) : 474- 477.
  • 6Nakata E, Hunter N, Mason K, et al. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy[J].Int J Radiat Oncol Biol Phys, 2004, 59(4) 1163-1173.
  • 7Platanias LC. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling[J].Pharmaeol Ther, 2003,98(2) : 129-142.
  • 8Liang J, Slingerland JM. Multiple roles of the PI3K/PKB(Akt) pathway in cell cycle progresion[J].Cell Cycle, 2003, 2 (4): 339-345.
  • 9Inoue K, Slaton JW, Perrotte P, et al. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody Im Clone C225 in mice with metastatic human bladder transitional cell carcinoma[J].Clin Cancer Res, 2000,6 (12)4874 -4884.
  • 10Ciardiello F, Bianco R, Damiano V, et al. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225[J]. Clin Cancer Res 1999,5(4) :909-916.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部